Publications (155) ROBERTO CARLOS DELGADO BOLTON publications

filter_list

2025

  1. Assessment of the therapeutic efficacy of [177Lu]Lu-PSMA-X compared to taxane chemotherapy in taxane-chemo-naïve patients with metastatic castration-resistant prostate cancer: A systematic review and meta-analysis

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 52, Núm. 3, pp. 936-954

  2. Characterizing the early relationship between covert narcissism and cognitive empathy in medical students: a cross-sectional study

    BMC medical education, Vol. 25, Núm. 1, pp. 57

  3. European Cancer Organisation Essential Requirements for Quality Cancer Care for ovarian cancer: Focus on the multidisciplinary team

    Tumori, Vol. 111, Núm. 1, pp. 11-19

  4. FAPI radiopharmaceuticals in nuclear oncology and theranostics of solid tumours: are we nearer to surrounding the hallmarks of cancer?

    Annals of Nuclear Medicine, Vol. 39, Núm. 5, pp. 407-423

  5. Factors Influencing Burnout in Croatian Medical Students: The roles of Lifelong Learning and Loneliness

    Perspectives on medical education, Vol. 14, Núm. 1, pp. 274-285

  6. Has the Time Come to Switch from Extensive Lymph Node Dissection to Sentinel Lymph Node Biopsy in Prostate Cancer Patients Treated with Radical Laparoscopic Prostatectomy?

    Clinical Nuclear Medicine, Vol. 50, Núm. 1, pp. 52-53

  7. Lymphoscintigraphy for the Evaluation of Primary Lymphedema: A Scoring System Aimed at Harmonizing the Procedure and Interpretation and Increasing Reproducibility

    Clinical Nuclear Medicine, Vol. 50, Núm. 3, pp. 219-220

  8. Perspective on Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided Surgery

    Journal of Nuclear Medicine, Vol. 66, Núm. 1, pp. 73-74

  9. Whole-body MRI Versus [18F]FDG PET/CT in Diagnosing and Monitoring Plasmacytomas: A Comparative Study

    Clinical Nuclear Medicine

  10. [177Lu]Lu-EDTMP —a bone pain palliating agent: pharmacokinetics, biodistribution, safety profile and clinical evaluation in osseous metastatic patients

    European Journal of Nuclear Medicine and Molecular Imaging

2024

  1. Bridging the Gap Between Clinical Suspicion of Neuroendocrine Tumors and Diagnosis With PET/CT When Pathology Is Unavailable: Considerations on Guidelines and Real Access to State-of-the-Art Molecular Imaging

    Clinical Nuclear Medicine

  2. Guardians of precision: advancing radiation protection, safety, and quality systems in nuclear medicine

    European Journal of Nuclear Medicine and Molecular Imaging, Vol. 51, Núm. 6, pp. 1498-1505

  3. ImmunoPET in high-grade neuroendocrine tumours

    The Lancet Oncology

  4. Medical Professionalism and Its Association with Dropout Intention in Peruvian Medical Students during the COVID-19 Pandemic

    Behavioral Sciences, Vol. 14, Núm. 8

  5. PSMA Radioligand Therapy in Prostate Cancer: Where Are We and Where Are We Heading?

    Clinical nuclear medicine, Vol. 49, Núm. 1, pp. 45-55

  6. Production and regulatory issues for theranostics

    The Lancet Oncology, Vol. 25, Núm. 6, pp. e260-e269

  7. Radioligand Therapy in Lymphoma: Past, Present, and Future

    PET Clinics, Vol. 19, Núm. 4, pp. 475-494

  8. Radiotherapy and theranostics: a Lancet Oncology Commission

    The Lancet Oncology, Vol. 25, Núm. 11, pp. e545-e580

2023

  1. A randomised trial probes the higher efficacy of a hybrid radioactive and fluorescent tracer approach in high-complexity sentinel node biopsy during robotic surgery of prostate cancer

    European Journal of Nuclear Medicine and Molecular Imaging

  2. Are We Approaching a Change in Paradigm in PET/CT Imaging of Solid Gastrointestinal (or Digestive) Tract Tumors with the Clinical Application of FAPI Imaging?

    Clinical Nuclear Medicine, Vol. 48, Núm. 4, pp. 318-319